Triple-action diabetes drug shows promise as Alzheimer's treatment

In a new paper published in the journal Brain Research, the researchers explain how the "triple-action" drug resulted in a significant reversal of memory loss in mice that were genetically engineered to develop human-like Alzheimer's disease.

The new drug "holds clear promise of being developed into a new treatment for chronic neurodegenerative disorders such as Alzheimer's disease," says study leader Christian Hölscher, a professor in the Faculty of Health and Medicine at Lancaster University in the U.K.

To read the full article, click HERE

Written by Catharine Paddock PhD for medicalnewstoday.com

(Photo Credit: www.medicalnewstoday.com)